Angélica Figueroa

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 11

Top Topics

Cancer Stem Cells

Radical Prostatectomy

Saccharomyces Cerevisiae

Top Venues

International journal of molecular sciences

Journal of proteome research

Archives of toxicology

This page only lists publications with an associated author ORCID identifier.

Publications

Gloria Alfonsín, Alberto Berral-González, Andrea Rodríguez-Alonso, Macarena Quiroga, Javier De Las Rivas, Angélica Figueroa
Stratification of Colorectal Patients Based on Survival Analysis Shows the Value of Consensus Molecular Subtypes and Reveals the CBLL1 Gene as a Biomarker of CMS2 Tumours. International journal of molecular sciences 25 (3) (2024)
Gloria Alfonsín, Alberto Berral-González, Andrea Rodríguez-Alonso, Macarena Quiroga, Javier De Las Rivas, Angélica Figueroa
Stratification of Colorectal Patients Based on Survival Analysis Shows the Value of Consensus Molecular Subtypes and Reveals the CBLL1 Gene as a Biomarker of CMS2 Tumours. International journal of molecular sciences 25 (3) (2024)
Gloria Alfonsín, Alberto Berral-González, Andrea Rodríguez-Alonso, Macarena Quiroga, Javier De Las Rivas, Angélica Figueroa
Stratification of Colorectal Patients Based on Survival Analysis Shows the Value of Consensus Molecular Subtypes and Reveals the CBLL1 Gene as a Biomarker of CMS2 Tumours. International journal of molecular sciences 25 (3) (2024)
Gloria Alfonsín, Alberto Berral-González, Andrea Rodríguez-Alonso, Macarena Quiroga, Javier De Las Rivas, Angélica Figueroa
Stratification of Colorectal Patients Based on Survival Analysis Shows the Value of Consensus Molecular Subtypes and Reveals the CBLL1 Gene as a Biomarker of CMS2 Tumours. International journal of molecular sciences 25 (3) (2024)
Gloria Alfonsín, Alberto Berral-González, Andrea Rodríguez-Alonso, Macarena Quiroga, Javier De Las Rivas, Angélica Figueroa
Stratification of Colorectal Patients Based on Survival Analysis Shows the Value of Consensus Molecular Subtypes and Reveals the CBLL1 Gene as a Biomarker of CMS2 Tumours. International journal of molecular sciences 25 (3) (2024)
Macarena Quiroga, Andrea Rodríguez-Alonso, Gloria Alfonsín, Juan José Escuder Rodríguez, Sara M Breijo, Venancio Chantada, Angélica Figueroa
Protein Degradation by E3 Ubiquitin Ligases in Cancer Stem Cells. Cancers 14 (4) (2022)
Javier De Las Rivas, Anamaria Brozovic, Sivan Izraely, Alba Casas-Pais, Isaac P Witz, Angélica Figueroa
Cancer drug resistance induced by EMT: novel therapeutic strategies. Archives of toxicology 95 (7) (2021)
Andrea Rodríguez-Alonso, Alba Casas-Pais, Daniel Roca-Lema, Begoña Graña, Gabriela Romay, Angélica Figueroa
Regulation of Epithelial-Mesenchymal Plasticity by the E3 Ubiquitin-Ligases in Cancer. Cancers 12 (11) (2020)
Olaia Martinez-Iglesias, Alba Casas-Pais, Raquel Castosa, Andrea Díaz-Díaz, Daniel Roca-Lema, Ángel Concha, Álvaro Cortés, Federico Gago, Angélica Figueroa
Hakin-1, a New Specific Small-Molecule Inhibitor for the E3 Ubiquitin-Ligase Hakai, Inhibits Carcinoma Growth and Progression. Cancers 12 (5) (2020)
Aida Barreiro-Alonso, María Cámara-Quílez, Martín Salamini-Montemurri, Mónica Lamas-Maceiras, Ángel Vizoso-Vázquez, Esther Rodríguez-Belmonte, María Quindós-Varela, Olaia Martínez-Iglesias, Angélica Figueroa, María Esperanza Cerdán
Characterization of HMGB1/2 Interactome in Prostate Cancer by Yeast Two Hybrid Approach: Potential Pathobiological Implications. Cancers 11 (11) (2019)
Andrea Díaz-Díaz, Alba Casas-Pais, Valentina Calamia, Raquel Castosa, Olaia Martinez-Iglesias, Daniel Roca-Lema, Isabel Santamarina, Manuel Valladares-Ayerbes, Lourdes Calvo, Venancio Chantada, Angélica Figueroa
Proteomic Analysis of the E3 Ubiquitin-Ligase Hakai Highlights a Role in Plasticity of the Cytoskeleton Dynamics and in the Proteasome System. Journal of proteome research 16 (8) (2017)